arrow
M

Maximilian Reichert

department of medicine ii
H指数:39
被引数:8,137

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis

KRAS致癌基因驱动的I型干扰素信号为胰腺癌的坏死性凋亡奠定基础

2026-06-150
OAAI
A disease model resource reveals core principles of tissue-specific cancer evolution

一个疾病模型资源揭示了组织特异性癌症演化的核心原则

Nature
IF48.5
2026-02-250
OAAI
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength

TIGIT干扰通过增强TCR信号强度,恢复了低亲和力TCR工程化T细胞的抗肿瘤活性。

2026-01-080
OA
c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT

c-Rel通过纤维连接蛋白-整合素信号通路诱导的隔离应激抵抗和EMT来驱动胰腺癌转移

2025-12-150
OAAI
GerPaCyst - The trial protocol of the prospective, multicenter, interdisciplinary German Pancreas Club Cyst Registry

GerPaCyst - 该前瞻性、多中心、跨学科德国胰腺俱乐部囊肿登记研究的试验方案

2025-11-251
PRE
Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncology

利用胰腺癌患者来源类器官开发转化放射生物学平台,用于个性化放射肿瘤学

2025-09-170
PREAI
Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in Germany

导航罕见癌症护理:基于德国一项全国性横断面研究的患者报告见解,涉及患者就医历程、诊断时间、决策制定和护理协调

2025-07-050
PRE
Activation of RAS/MEK/ERK signalling drives biliary differentiation in primary liver cancer

RAS/MEK/ERK信号通路的激活驱动原发性肝癌的胆管分化

GUT
IF25.8
2025-05-120
PRE
Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma
2024-12-100
OAAI
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
2024-10-011
PRE
KRASG12C-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening

胰腺癌的KRASG12C-inhibitor-based联合治疗: 来自药物筛选的见解

2024-09-100
OA
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction

一种新的AMPK抑制剂使胰腺癌细胞对铁死亡诱导敏感

2024-06-172
OA
An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies
2024-02-012
PRE